Who
Gina Consylman
Director
Company insider
Files Form 4 as: Director, Assembly Biosciences; Chief Financial Officer, bluebird bio; Director, Verastem; SVP, CFO & Treasurer, Ironwood Pharmaceuticals; VP-Controller, Analogic.
In numbers
- Trades disclosed
- 99
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $897K
- Companies
- 5
- Companies where not an officer
- 2
- First trade
- 10 Sep 2012
- Last trade
- 4 Jun 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 5 Jun 2026 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 4 Jun 2026filed 5 Jun 2026 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,000 at $0.00 | filing |
| 5 Jun 2025filed 9 Jun 2025 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,500 at $0.00 | filing |
| 29 May 2024filed 30 May 2024 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,750 at $0.00 | filing |
| 25 May 2023filed 30 May 2023 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 1 Feb 2022filed 3 Feb 2022 | bluebird biooption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Feb 2022filed 3 Feb 2022 | bluebird bio | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 11 Nov 2021filed 16 Nov 2021 | bluebird biooption or derivative | SEC FORM 4 Code J | —170,655 at $0.00 | filing |
| 11 Nov 2021filed 16 Nov 2021 | bluebird bio | SEC FORM 4 Code J | —100,385 at $0.00 | filing |
| 28 Jun 2021filed 30 Jun 2021 | VSTM Verastemoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 20 May 2021filed 24 May 2021 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 26 Mar 2021filed 30 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —56,372 at $0.00 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $24K2,657 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $23K2,527 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $57K6,242 at $9.11 | filing |
| 26 Feb 2021filed 2 Mar 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $64K6,980 at $9.11 | filing |
| 22 Feb 2021filed 24 Feb 2021 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Code A | —84,951 at $0.00 | filing |
| 9 Nov 2020filed 10 Nov 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $9,009825 at $10.92 | filing |
| 9 Nov 2020filed 10 Nov 2020 | IRWD Ironwood PharmaceuticalsPharmaceuticals | SEC FORM 4 Sold | $6,443590 at $10.92 | filing |
News
No headline names them, or the companies they trade most, lately.